Intracellular Delivery: v. 1
Nanocarrier Formulation
Ales Prokop(Editor)
Springer (Publisher)
Published on 3. October 2011
Book
Hardback
10 pages
978-94-007-2050-3 (ISBN)
Description
This book features a special subsection of Nanomedicine, an application of nanotechnology to achieve breakthroughs in healthcare. It exploits the improved and often novel physical, chemical and biological properties of materials only existent at the nanometer scale. As a consequence of small scale, nanosystems in most cases are efficiently uptaken by cells and appear to act at the intracellular level. Nanotechnology has the potential to improve diagnosis, treatment and follow-up of diseases, and includes targeted drug delivery and regenerative medicine; it creates new tools and methods that impact significantly existing conservative practices.
More details
Edition
Edition. ed.
Language
English
Place of publication
Dordrecht
Netherlands
Target group
Professional and scholarly
Research
Illustrations
10 farbige Abbildungen
10 colour illustrations
Dimensions
Height: 235 mm
Width: 155 mm
ISBN-13
978-94-007-2050-3 (9789400720503)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Person
Dr Ales Prokop is a retired Professor of Chemical Engineering (Vanderbilt University, Nashville, USA). Throughout his long and varied career he has always worked at the boundary between biology, medicine and engineering and has gained a unique insight into the many disciplines required to discover and develop effective therapies. Having taken a first degree in engineering (MSc, Prague) he gained a doctorate in Microbiology (PhD, Prague) and then a further degree in Biology (DSc, Prague). Throughout his career he has concentrated on biotechnology and bioengineering and has gained considerable expertise in the vital links between those two areas. The systems approach has been a leading theme of his scientific work and he has been able to apply the knowledge gained to the commercial arena. Latterly, he has worked in the area of bioartificial organs, drug delivery and systems biology. He is the author of over 160 publications and reviews in scientific journals and books and he has organized several international meetings and symposia. He has always felt it vitally important to transfer his scientific research, knowledge and results into practice and has collaborated with many companies and scientists in the pharmaceutical arena in both research and teaching.